Miragen Therapeutics Stock Price - MGEN

1.04
0.00 (0.0%)
1.04
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Miragen Therapeutics Inc MGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 1.04 0.00 0.00 0.00 1.04 04:38:25
Bid Price Ask Price Spread Spread % News
0.9305 1.04 0.1095 10.53% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.04 USD

Miragen Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 55.20M 53.08M 51.85M $ 4.46M $ - -1.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 6.00 2.30%

more financials information »

Miragen Therapeutics News

Date Time Source News Article
5/22/202017:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/22/202017:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/22/202017:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/22/202017:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/22/202017:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/22/202017:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/22/202016:16Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.69461.190.651.043,839,2000.345449.73%
1 Month0.58481.190.54510.91430091,464,1340.455277.84%
3 Months0.661.190.3110.7092433906,6270.3857.58%
6 Months0.802.930.3111.071,815,4480.2430.0%
1 Year2.362.930.3111.091,025,477-1.32-55.93%
3 Years11.0815.90990.3112.28461,766-10.04-90.61%
5 Years11.1118.000.3112.35422,588-10.07-90.64%

Miragen Therapeutics Description

Miragen Therapeutics Inc is a US-based clinical-stage biopharmaceutical company discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. Its clinical-stage product candidates include Cobomarsen (MRG-106), Remlarsen (MRG-201), MRG-229, and MRG-110. The company mainly focuses on developing such therapeutics which will target blood cancers, pathological fibrosis, and revascularization.
Your Recent History
NASDAQ
MGEN
Miragen Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200603 09:14:56